Merck & Co Inc
NYSE: MRK
$96.20
-$2.17 (-2.2%)
Real Time Data Delayed 15 Min.
MRK Articles
Once Eliot Spitzer left his office as prosecutor to become governor of New York State many feared that there would be no one left to devil large corporations and Wall St. firms. The fears were...
Published:
If a company like Merck (MRK) is going to overcome problems with a lot its drugs going "off patent" it is going to have to come up with some new ways to make money. One is to offer its drugs...
Published:
According to Reuters, Capital One has warned that it will have lower than expected earnings. Reuters reports that Goldman Sachs (GS) sees a recession this year. Reuters reports that Tata (TTM) has...
Published:
We are updating our list of tier-one Defensive Stocks since so many of these stocks have run up and since lists need continual updating. Our originally updated list of tier one defensive stocks was...
Published:
Last Updated:
According to Reuters, Berkshire Hathaway (BRK) has bought control of Marmon Industries for $4.5 billion. Reuters writes that US retail sales were up a disappointing 3.6% for the holidays. Reuters...
Published:
According to Reuters India’s Tata is about to close a deal to buy Jaguar and Rover from Ford (F). Reuters writes that the IMF says that the subprime mortgage problem will slow growth in the US...
Published:
Early this week we are running a list of stocks that have been in a turnaround plan, yet the stocks and the businesses haven’t turned around. Could these be the stocks to watch for 2008? Pfizer...
Published:
Last Updated:
According to Reuters, Citigroup (C) will take $49 billion of SIVs onto its balance sheet. Reuters writes that Nissan and Chrysler may begin to partner in building new cars Reuters reports that Acer...
Published:
Merck (MRK) is not going to do as well as Wall St. had hoped next year. It guided to $3.28 to $3.38 earnings per share. A Reuters poll puts the number at $3.27. Merck shares have been near a 52-week...
Published:
Allscripts (MDRX) traded down 25% after missing earnings estimates and after lower guidance for 2007 and 2008. American Tower (AMT) replacing Alltel (AT) in S&P. ARM Holdings plc (ARMHY) trading...
Published:
It has been a bloody and bitter fight. Merck’s (MRK) pain killer Vioxx has been alleged to cause heart problems and worse. The drug hit the market in 1999 and was pulled in 2004. At that point the...
Published:
The markets haven’t fallen apart after yesterday’s 360 point dive on the DJIA, but we are still trading a tad lower today. Now that Cisco Systems is showing you can’t just automatically hide...
Published:
GTx, Inc. (NASDAQ: GTXI) is seeing shares trade sharply higher on a collaboration pact with Merck (NYSE: MRK). The biotech and drug giant pact is for research and development and a strategic...
Published:
With the markets down so much today on the financial stock fallout after the Citi downgrade/concern and with oil stocks listing lower after the Exxon miss, we wanted to show a brief comparison of...
Published:
Last Updated:
Merck (MRK) announced third-quarter 2007 earnings per share of $0.75, excluding restructuring charges, and third-quarter reported EPS of $0.70. Worldwide sales were $6.1 billion for the quarter, an...
Published: